drugset / Trial / NCT02517307

Fatty Acid Oxidation Defects and Insulin Sensitivity

NCT02517307 ↗

Completed 41 enrolled Oregon Health and Science University
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to learn more about what causes insulin resistance. It has been suggested that proper breakdown of fat into energy (oxidation) in the body is important to allow insulin to keep blood sugar in the normal range. The investigators want to know if having one of the fatty acid oxidation disorders could have an influence on insulin action. Fatty acid oxidation disorders are genetic disorders that inhibit one of the enzymes that converts fat into energy. The investigators will study both normal healthy people and people with a long-chain fatty acid oxidation disorder.

Timeline

Start
2016-02
Primary completion
2021-01
Completion
2021-03

Outcome

Missed primary endpoint

registry analysis (other test); Glycerol/Saline FAOD vs Intralipid FAOD vs Glycerol/Saline Control vs Intralipid Control; p = 0.136; Mixed Models Analysis NCT02517307 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycerol Small molecule — —
Subject Intralipid Other / unclassified — —
Background Heparin Other / unclassified — —